BACKGROUND. Calcium supplementation has been reported to reduce blood pressure in pregnant and nonpregnant women. We undertook this prospective study to determine the effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy (gestational hypertension and preeclampsia) and to determine the value of urinary calcium levels as a predictor of the response. METHODS. We studied 1194 nulliparous women who were in the 20th week of gestation at the beginning of the study. The women were randomly assigned to receive 2 g per day of elemental calcium in the form of calcium carbonate (593 women) or placebo (601 women). Urinary excretion of calcium and creatinine was measured before calcium supplementation was begun. The women were followed to the end of their pregnancies, and the incidence of hypertensive disorders of pregnancy was determined. RESULTS. The rates of hypertensive disorders of pregnancy were lower in the calcium group than in the placebo group (9.8 percent vs. 14.8 percent; odds ratio, 0.63; 95 percent confidence interval, 0.44 to 0.90). The risk of these disorders was lower at all times during gestation, particularly after the 28th week of gestation (P = 0.01 by life-table analysis), in the calcium group than in the placebo group, and the risk of both gestational hypertension and preeclampsia was also lower in the calcium group. Among the women who had low ratios of urinary calcium to urinary creatinine (less than or equal to 0.62 mmol per millimole) during the 20th week of gestation, those in the calcium group had a lower risk of hypertensive disorders of pregnancy (odds ratio, 0.56; 95 percent confidence interval, 0.29 to 1.09) and less of an increase in diastolic and systolic blood pressure than the placebo group. The pattern of response was similar among the women who had a high ratio of urinary calcium to urinary creatinine during the 20th week of gestation, but the differences were smaller. CONCLUSIONS. Pregnant women who receive calcium supplementation after the 20th week of pregnancy have a reduced risk of hypertensive disorders of pregnancy.
Source Information
Centro Rosarino de Estudios Perinatales, Argentina.
This article has been cited by other articles:
Jarjou, L. M., Prentice, A., Sawo, Y., Laskey, M A., Bennett, J., Goldberg, G. R, Cole, T. J
(2006). Randomized, placebo-controlled, calcium supplementation study in pregnant Gambian women: effects on breast-milk calcium concentrations and infant birth weight, growth, and bone mineral accretion in the first year of life. Am. J. Clin. Nutr.
83: 657-666
[Abstract][Full Text]
Gillman, M. W., Rifas-Shiman, S. L., Kleinman, K. P., Rich-Edwards, J. W., Lipshultz, S. E.
(2004). Maternal Calcium Intake and Offspring Blood Pressure. Circulation
110: 1990-1995
[Abstract][Full Text]
Villar, J., Merialdi, M., Gulmezoglu, A. M., Abalos, E., Carroli, G., Kulier, R., de Onis, M.
(2003). Nutritional Interventions during Pregnancy for the Prevention or Treatment of Maternal Morbidity and Preterm Delivery: An Overview of Randomized Controlled Trials. J. Nutr.
133: 1606S-1625
[Abstract][Full Text]
Villar, J., Merialdi, M., Gulmezoglu, A. M., Abalos, E., Carroli, G., Kulier, R., de Onis, M.
(2003). Characteristics of Randomized Controlled Trials Included in Systematic Reviews of Nutritional Interventions Reporting Maternal Morbidity, Mortality, Preterm Delivery, Intrauterine Growth Restriction and Small for Gestational Age and Birth Weight Outcomes. J. Nutr.
133: 1632S-1639
[Full Text]
Jolma, P., Kalliovalkama, J., Tolvanen, J.-P., Koobi, P., Kahonen, M., Hutri-Kahonen, N., Wu, X., Porsti, I.
(2000). High-calcium diet enhances vasorelaxation in nitric oxide-deficient hypertension. Am. J. Physiol. Heart Circ. Physiol.
279: H1036-H1043
[Abstract][Full Text]
Ritchie, L. D, King, J. C
(2000). Dietary calcium and pregnancy-induced hypertension: is there a relation?. Am. J. Clin. Nutr.
71: 1371S-1374
[Abstract][Full Text]
Villar, J., Belizan, J. M
(2000). Same nutrient, different hypotheses: disparities in trials of calcium supplementation during pregnancy. Am. J. Clin. Nutr.
71: 1375S-1379
[Abstract][Full Text]
Norwitz, E. R., Repke, J. T.
(2000). Preeclampsia Prevention and Management. Reproductive Sciences
7: 21-36
[Abstract]
Ananth, C. V., Berkowitz, G. S., Savitz, D. A., Lapinski, R. H.
(1999). Placental Abruption and Adverse Perinatal Outcomes. JAMA
282: 1646-1651
[Abstract][Full Text]
DerSimonian, R., Levine, R. J.
(1999). Resolving Discrepancies Between a Meta-analysis and a Subsequent Large Controlled Trial. JAMA
282: 664-670
[Abstract][Full Text]
Goldenberg, R. L., Rouse, D. J.
(1998). Prevention of Premature Birth. NEJM
339: 313-320
[Full Text]
Belizan, J. M, Villar, J., Bergel, E., del Pino, A., Di Fulvio, S., Galliano, S. V, Kattan, C.
(1997). Long term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ
315: 281-285
[Abstract][Full Text]
Levine, R. J., Hauth, J. C., Curet, L. B., Sibai, B. M., Catalano, P. M., Morris, C. D., DerSimonian, R., Esterlitz, J. R., Raymond, E. G., Bild, D. E., Clemens, J. D., Cutler, J. A., Ewell, M. G., Friedman, S. A., Goldenberg, R. L., Jacobson, S.-L., Joffe, G. M., Klebanoff, M. A., Petrulis, A. S.
(1997). Trial of Calcium to Prevent Preeclampsia. NEJM
337: 69-77
[Abstract][Full Text]
Makynen, H., Kahonen, M., Wu, X., Arvola, P., Porsti, I.
(1996). Endothelial Function in Deoxycorticosterone-NaCl Hypertension : Effect of Calcium Supplementation. Circulation
93: 1000-1008
[Abstract][Full Text]
(1991). CALCIUM PROTECTS AGAINST HYPERTENSION IN PREGNANCY. JWatch General
1991: 2-2
[Full Text]
Previous
